Jun 27, 2025 3-5pm ET
Friday on The Robert Scott Bell Show:
Hour 1
Feds Have Lost the Plot on Nutrition The article argues that federal nutrition policy has strayed far from its original intent—using food as medicine—and now supports ultra-processed, disease-promoting meals through programs like Medicaid while restricting access to nutrient-dense therapeutic foods. It highlights that current public health spending is perpetuating poor dietary habits by funding foods that undermine metabolic health rather than promoting healing. The piece criticizes the disconnect between evidence-based nutritional science and federal policy, noting that allowance of industrial, edible products in place of real whole foods often leaves patients reliant on medical interventions instead of preventive nourishment. Further, the article stresses that the system incentivizes food-as-business models over food-as-health models, arguing for policy reform to redirect federal funds toward natural, whole foods, therapeutic diets, and low-processed options. The authors advocate for restructured benefit structures, such as Medicaid reimbursement for food-as-medication, and removal of subsidies and supports for ultra-processed food production. They claim such changes could reverse chronic disease trends and reduce healthcare costs. Ultimately, the article frames the current federal approach as a contradiction: regulations intended to improve public health are instead bolstering poor diets, patient dependency, and profit-driven food industries—while failing to treat nutrition as a foundational pillar of health.
Texas Gov. Greg Abbott Signs Bill Taking MAHA To Next Level Governor Abbott has enacted Senate Bill 25—dubbed the Make Texas Health Again Act—which institutionalizes the MAHA initiative at the state level. The bill establishes a nutrition advisory committee within the Department of State Health Services composed of experts in metabolic health, functional medicine, and chronic disease. Its core mandates include a review of the health impacts of ultra-processed foods, artificial additives, and food dyes, and recommendations for warning labels on 44 identified substances. The legislation also empowers the committee to evaluate scientific studies, advise on metabolic disease risks, and encourage educational campaigns for consumers. Supporters argue the bill will drive evidence-based dietary improvements, help counter obesity and chronic illness, and enable a bottom-up revival of nutritional quality. They frame the move as state-level correction for federal nutrition policies that ignore food processing harms. Critics, however, contend that mandating warning labels and shifting labels toward additive caution could confuse consumers, overstate risks, and potentially stigmatize safe, FDA-approved foods. The push may also disrupt large-scale food manufacturers and supply chains within the state. Nonetheless, the measure signals a growing trend: states adopting autonomous dietary strategies aligned with MAHA’s emphasis on real food, nutrition transparency, and systemic health reform, positioning Texas as a laboratory for national dietary policy experimentation.
Hundreds of weight loss and diabetes jab users report pancreas problems Nearly 400 reports of acute pancreatitis have been linked to the use of GLP‑1 receptor agonist drugs—including tirzepatide (Mounjaro), semaglutide (Ozempic, Wegovy), and liraglutide—according to the UK’s Medicines and Healthcare products Regulatory Agency (MHRA). The largest share of cases involves Mounjaro, which alone accounts for 181 reports. These drugs, originally approved for diabetes management but now widely prescribed for weight loss, have surged in popularity due to their effectiveness in reducing body weight. However, symptoms such as severe abdominal pain, nausea, vomiting, and fever have led to hospitalizations in some users, with ongoing investigations into potential fatalities. In response, the MHRA has partnered with Genomics England to study whether genetic predispositions might explain increased risks, launching a pharmacogenomic initiative through its Yellow Card Biobank. Although the number of cases remains small relative to the millions using these medications, regulators and healthcare providers are being urged to re-evaluate risk–benefit considerations, especially in off-label use scenarios. The findings also raise broader concerns about long-term safety, data transparency, and post-market surveillance in an era of accelerated drug approvals and consumer-driven demand. The FDA and EMA are monitoring developments closely, and additional guidance or labeling changes may follow.
The Icarian Gene: The Rise and Fall of the Expert Class Justice Clarence Thomas’ concurrence in United States v. Skrmetti, upholding Tennessee’s ban on adolescent transgender treatments, highlights a growing distrust in the “expert class” that has long shaped U.S. policy and legal outcomes, often disregarding public sentiment. Thomas warned that allowing “elite sentiment” to suppress democratic debate threatens democracy itself, a concern echoed by the article’s critique of technocracy—government by experts. This expert class, once revered for objectivity, has lost public trust by replacing neutral inquiry with ideological orthodoxy, particularly in fields like public health, gender studies, and higher education. The article draws on the myth of Icarus, suggesting that experts, driven by hubris, have overreached by prioritizing advocacy over evidence, leading to their decline in credibility. For instance, public skepticism grew during the COVID-19 pandemic when experts like Dr. Anthony Fauci dismissed alternative theories, such as the lab-leak hypothesis, only for them to gain later traction “‘We should always be skeptical of experts who are never skeptical themselves’ is a quote by Turley that reflects the loss of trust in experts.” Higher education is criticized for fostering a generation of scholars who abandon neutrality for social activism, further eroding public confidence. The article argues that this shift from objective analysis to dogmatic assertions has alienated the public, who increasingly reject expert claims that conflict with observable reality, such as gender as a social construct. The fall of this class is attributed to their failure to maintain intellectual integrity, risking long-term damage to democratic discourse and institutional trust.
Welcome back to another “Homeopathic Hits” episode on The Robert Scott Bell Show!
Today we spotlight Heloderma, a fascinating remedy sourced from the venom of the Gila monster. Far from dangerous in its potentized form, this remedy specializes in conditions where the body grows cold, nerves go numb, and movement falters.
If you’re battling sensations of being frozen from the inside out, Heloderma may offer the warmth and restoration your system needs.
Download the Information Sheet
Hour 2
Vaccine Makers Signal Fear Over Removal of Neurotoxic Injected Aluminum Ingredient Former FDA Commissioner Scott Gottlieb’s appearance on CNBC following an ACIP committee vote to remove thimerosal from certain flu vaccines sparked renewed controversy as he defended the continued use of aluminum adjuvants in childhood immunizations. Gottlieb repeatedly invoked the term “anti-vaxxer” while attempting to frame critics of vaccine ingredients as fringe, despite growing scrutiny of aluminum nanoparticles injected into infants and children. According to the article, the CDC and NIH have failed to provide any safety studies supporting the use of injected aluminum, despite legal demands submitted by the Informed Consent Action Network (ICAN) in 2019. A 2021 study revealed several childhood vaccines contain more aluminum than listed on product labels, prompting further challenges to the FDA to verify proper disclosure—efforts that have reportedly been stonewalled. The only cited justification for aluminum safety is a 2011 FDA study by Dr. Robert Mitkus, which used infused aluminum citrate in adults rather than injected aluminum hydroxide in infants—an approach critics argue is scientifically indefensible. World researchers have echoed concerns, citing the absence of official experimental investigation into aluminum adjuvants despite their known neurotoxicity. The article concludes with a broader critique of Gottlieb’s post-FDA role at Pfizer and his recurring presence in media, portraying him as a key defender of the pharmaceutical industry’s interests amid mounting public pressure for greater transparency and regulatory accountability.
Special Guest – Michael Boldin
Five Constitutional Truths They Don’t Want You to Know The U.S. Constitution is often misunderstood due to deliberate obfuscation by those in power, and five key truths reveal its core principles: the Constitution is a compact among states, not a grant of unlimited federal power; it strictly limits federal authority to enumerated powers; states retain broad sovereignty to act independently; the Bill of Rights was intended to protect individual liberties from federal overreach; and the Second Amendment explicitly protects an individual’s right to bear arms for self-defense. The article argues that centralized power seeks to obscure these truths to expand federal control, citing historical debates like those between Federalists and Anti-Federalists, who feared a strong central government. For example, the Tenth Amendment underscores that powers not delegated to the federal government are reserved to the states or the people, yet modern interpretations often ignore this. The article highlights how the commerce clause has been misused to justify expansive federal laws, contrary to the Founders’ intent. Similarly, the Second Amendment’s clear language is muddled by claims it only applies to militias, despite Supreme Court rulings like District of Columbia v. Heller affirming individual rights. These distortions, the article asserts, undermine the Constitution’s role as a check on federal power, urging citizens to reclaim these truths to resist overreach.
Corruption: The Founders Warned Us About Ourselves The Founders of the U.S. Constitution recognized human nature’s susceptibility to corruption, designing a system of checks and balances to limit power and prevent tyranny, as they believed ambition and self-interest could corrupt even well-intentioned leaders. They drew from historical examples like Rome’s fall and their own experiences with British overreach, emphasizing that power must be divided among branches and levels of government. James Madison, in Federalist No. 51, argued that ambition must counteract ambition, with each branch checking the others to protect liberty. The article notes the Founders’ warnings about centralized power, as seen in Anti-Federalist fears that a strong federal government could erode state sovereignty. They anticipated threats like bribery, factionalism, and moral decay, which could undermine the republic. For instance, George Mason warned that unchecked power could lead to oppression, advocating for frequent elections and term limits. The article connects these concerns to modern issues, suggesting that ignoring these principles has led to an overreaching federal government. The Founders’ solution—strict adherence to constitutional limits, decentralized power, and civic virtue—remains critical to combating corruption, with the article urging citizens to hold officials accountable to preserve the republic’s integrity.
Methylene Blue Emerges as an Adjunct in Septic Shock Methylene blue, a century-old dye, shows promise as an adjunct therapy in septic shock, potentially reducing vasopressor requirements and ICU stays, though it does not replace standard treatments. Research indicates it improves tissue perfusion by inhibiting nitric oxide overproduction, which contributes to vasodilation in septic shock, a life-threatening condition with a 30-40% mortality rate. Studies, including a 2023 meta-analysis, found that methylene blue reduced vasopressor duration by about 1.5 days and shortened ICU stays, with some trials reporting lower mortality rates in treated groups. However, results are inconsistent, as a 2024 study showed no significant mortality benefit, highlighting the need for further research on optimal dosing, timing, and patient selection. The drug’s affordability and availability make it appealing, especially in resource-limited settings, but its use remains off-label, requiring careful monitoring due to potential side effects like pulmonary hypertension at high doses. Experts emphasize that methylene blue should complement, not replace, standard care like antibiotics and fluid resuscitation. Ongoing trials aim to clarify its role, but current evidence suggests it could be a valuable tool in managing septic shock, particularly for patients unresponsive to conventional therapies, pending more robust data.
New GMO Alert: GMO Rice Isn’t on the Market, but It’s Still Showing Up Genetically modified (GMO) rice, not approved for commercial sale, has been detected in global food supplies, raising concerns about regulatory gaps and unintended environmental impacts. Specifically, unapproved strains like Bayer’s LibertyLink and China’s Bt rice have appeared in U.S. and European markets, with contamination traced to field trials and illegal cultivation. For instance, in 2006, LibertyLink rice disrupted U.S. exports, costing farmers millions, while recent tests in 2024 found GMO rice in shipments from Asia. The article highlights that these incidents stem from inadequate oversight, as field trials often lack containment measures, allowing crossbreeding with non-GMO crops. This threatens organic and conventional farmers, who face economic losses and certification issues. Environmental risks include gene flow to wild rice, potentially altering ecosystems. Regulatory bodies like the USDA and EU have responded with stricter testing, but enforcement varies globally, especially in countries with weaker biosafety laws. The article calls for stronger international regulations, improved monitoring, and transparency to prevent unauthorized GMO spread. Consumer awareness and labeling are also emphasized to protect choice and safety, as the long-term health and ecological effects of these unapproved strains remain understudied.
Are We Ready for Bugs at Dinner, or Is the World Just Not That Hungry for Change? Edible insects are promoted as a sustainable protein source to address global food insecurity and environmental concerns, but cultural resistance and scalability challenges hinder widespread adoption. Insects like crickets and mealworms require less water, land, and feed than traditional livestock, producing up to 80% fewer greenhouse gas emissions, according to a 2023 FAO report. They are nutrient-rich, offering high protein and micronutrients, and are consumed by over 2 billion people globally, particularly in Africa and Asia. However, in Western countries, the “yuck factor” remains a significant barrier, with surveys showing 60-70% of consumers in Europe and North America unwilling to try insects due to taste, texture, or cultural norms. Regulatory hurdles, such as the EU’s strict novel food laws, and inconsistent safety standards globally complicate market growth. Production costs, while lower than meat, remain high for large-scale farming, and consumer education is needed to shift perceptions. Pilot programs, like insect-based snacks in Singapore, show promise, but scaling requires investment in processing and marketing to make products palatable. The article concludes that while insects could reduce reliance on unsustainable meat production, cultural and economic barriers suggest the world is not yet ready for widespread change.Remember Friends, The Power to Heal is Yours!
